CA-HOTWIRE
Hotwire, the global tech communications consultancy, is welcoming new leaders as the company continues further expansion of its capabilities and adds new, innovative brands to the client roster.
Hotwire is building on its strategic acquisition of McDonald Butler Associates to unlock new possibilities of growth and present clients with a more robust communications offering and access to new skills and services. This new level of communication has been designed to build brand reputation, strengthen stakeholder relationships and deliver revenue growth, igniting the entire marketing ecosystem and supporting CMOs in growing their businesses.
“Technology and innovation leaders are continuing to manage complexity and are seeking out solutions to support,” said Heather Kernahan, global CEO of Hotwire. “This year we took steps to narrow the gaps that exist between marketing and sales with new integrated offerings and strengthened our relationships with clients as they navigated major shifts in their business. We’re also working with some amazing new brands and deepening our expertise and leadership across key areas of the business.”
New Leaders Support Rapid Growth
Hotwire continues to add senior leaders in strategy, planning, digital and client consulting to its teams across the world. This past quarter key hires have been made in Germany, the U.K., and the U.S.
In Germany, Martin Opercan joined Hotwire as a Senior Director, Strategic Growth and will be responsible for client strategy and planning. Martin brings over 20 years of experience in marketing, communications and business development and most recently oversaw the Munich office for diffferent.
Rebecca Rhodes and Anastasia Pavolva recently joined the Hotwire U.K. team. Rebecca is Head of Planning and before joining Hotwire, ran her own consultancy, SuperHuman and also previously was Global Chief Creative Officer at Golin. Anastasia is a Strategy Director with experience working in global agencies such as Ogilvy and in brand management at Procter & Gamble.
In the U.S., two new Senior Vice Presidents will join the leadership and client services team. Andrea Holland has worked in tech comms across large global brands including Intuit, PayPal and LegalZoom as well as early stage B2C tech startups. Andrea is a PR instructor and author for LinkedIn Learning and most recently ran her own consultancy, DialedPR. She also founded the nation's #1 jobs site for PR professionals looking for remote work, RemotePRJobs . Jessica Heagerty comes to Hotwire from Dell Technologies where she held roles in Analyst Relations and Field Marketing. Jessica started her career working for global brands in leading communications agencies.
Tech Innovators Choose Hotwire to Ignite New Opportunities
As Hotwire continues to provide a new level of communication expertise helping companies build brand reputation, strengthen stakeholder relationships and deliver revenue growth, it’s igniting the entire marketing ecosystem and supporting ambitious companies in growing their businesses.
New clients include fast growing and global innovators who selected Hotwire for its technology and innovation expertise and consultancy approach. Most recently, Hotwire signed on Aircall, BAM Karaoke, Bright Machines, Cobrainer, QA, Rocket App and Splashtop.
Award Winning Client Work and Global Recognition
Hotwire and individuals across the agency continue to gain recognition for leadership and impactful client work. Ludi Garcia, Managing Director of Hotwire Spain, was recently recognized as the #1 most admired communications professional in Spain by SCOPEN and Hotwire was named Best Comms PR consultancy, as voted for by PR professionals working in agencies.
Hotwire’s work on Zoomtopia, Zoom’s annual conference, received Honorable Mention for Ragan Comms' Media Relations Award for Virtual Event and is shortlisted in the PR report awards.
The company was also recently named in the Propel 100 list as one of the most influential PR agencies in the world in 2021.
Expanding Partnerships in The Tech Ecosystem
Hotwire is partnering with organizations across the world who are working to advance technology innovation and the leaders pushing the industry forward. The company is now a member of Tech UK , which brings together people, companies and organizations to realize the positive outcomes of what digital technology can achieve.
Hotwire is also a sponsor for Get On Board , which is a week of education and training to prepare women leaders for Board positions. The company is also a sponsor of Alley to the Valley , a community of accomplished women who fast-track business opportunities for each other. Hotwire supports board readiness and women in leadership with Executive Thought Leadership and Media Training and Speaker Readiness services.
To learn more about Hotwire, visit https://www.hotwireglobal.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210930005562/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom